Encapsulating darunavir nanocrystals within Eudragit L100 using coaxial electrospraying

Graphical abstract No caption available. Abstract Electrospraying is renowned for its simplicity and versatility, and which can effectively produce particles with well‐controlled size, size distribution, particle shape, morphology and microstructure at the nano/microscale. In this study, coaxial electrospraying was used to investigate its feasibility for preparing nanoparticles made up of nanocrystals encapsulated within a polymer shell. Firstly, aqueous nanosuspensions of darunavir were prepared by wet media milling. Then the nanosuspension and solutions of an enteric polymer, Eudragit L100, were used as the inner/core liquid and outer/shell liquid in a coaxial electrospraying setup, respectively. As long as a sufficiently high voltage was applied, a stable Taylor cone‐jet mode was obtained to produce very fine core‐shell structure nanoparticles with high darunavir encapsulation efficiency of approximately 90%. The influence of the starting nanosuspension and the flow rates on the characteristics of the final electrosprayed particles was also evaluated. Using an optimized nanosuspension with reasonable size, size distribution and flow rates, the enteric coating layer reduced the percentage of DRV release in acidic medium in the in vitro dissolution test to ca. 20%. This study indicates that coaxial electrospraying is a potential and unique technique for encapsulating drug nanocrystals within a polymeric shell.

[1]  Christel A. S. Bergström,et al.  Compromised in vitro dissolution and membrane transport of multidrug amorphous formulations. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Dianrui Zhang,et al.  Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system , 2008 .

[3]  Yazhou Wang,et al.  Fabrication of core–shell micro/nanoparticles for programmable dual drug release by emulsion electrospraying , 2013, Journal of Nanoparticle Research.

[4]  J. Marijnissen,et al.  Producing Pharmaceutical Particles via Electrospraying with an Emphasis on Nano and Nano Structured Particles - A Review , 2010 .

[5]  M. Vanstockem,et al.  Solid state characterization of the anti-HIV drug TMC114: interconversion of amorphous TMC114, TMC114 ethanolate and hydrate. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[6]  Patrick Augustijns,et al.  Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. , 2008, International journal of pharmaceutics.

[7]  Niklas Sandler,et al.  Pharmaceutical co-crystals-an opportunity for drug product enhancement. , 2009, Expert opinion on drug delivery.

[8]  Barrett E. Rabinow,et al.  Nanosuspensions in drug delivery , 2004, Nature Reviews Drug Discovery.

[9]  T. Wisleder,et al.  Size-dependent melting point depression of nanostructures: Nanocalorimetric measurements , 2000 .

[10]  A. Florence,et al.  Changes in crystallinity and solubility on comminution of digoxin and observations on spironolactone and oestradiol * , 1976, The Journal of pharmacy and pharmacology.

[11]  G. Mooter,et al.  The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate. , 2012, Drug discovery today. Technologies.

[12]  Yixiang Xu,et al.  Electrospray encapsulation of water-soluble protein with polylactide. Effects of formulations on morphology, encapsulation efficiency and release profile of particles. , 2006, International journal of pharmaceutics.

[13]  K. Leong,et al.  Electrohydrodynamics: A facile technique to fabricate drug delivery systems. , 2009, Advanced drug delivery reviews.

[14]  Tudor I. Oprea,et al.  BDDCS Applied to Over 900 Drugs , 2011, The AAPS Journal.

[15]  R. Müller,et al.  Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.

[16]  N. Trasi,et al.  Dissolution performance of binary amorphous drug combinations--Impact of a second drug on the maximum achievable supersaturation. , 2015, International journal of pharmaceutics.

[17]  Xiaohong Li,et al.  Electrosprayed Microparticles with Loaded pDNA-Calcium Phosphate Nanoparticles to Promote the Regeneration of Mature Blood Vessels , 2013, Pharmaceutical Research.

[18]  P Amsa,et al.  Nanosuspensions: A Promising Drug Delivery Strategy , 2010 .

[19]  Miss A.O. Penney (b) , 1974, The New Yale Book of Quotations.

[20]  G. Van den Mooter,et al.  Pharmaceutical Applications of Electrospraying. , 2016, Journal of pharmaceutical sciences.

[21]  S N Jayasinghe,et al.  Electrohydrodynamic atomization of protein (bovine serum albumin) , 2005, Journal of materials science. Materials in medicine.

[22]  Rajeswari Challa,et al.  Cyclodextrins in drug delivery: An updated review , 2005, AAPS PharmSciTech.

[23]  G. McKinley,et al.  Dispersity and spinnability: Why highly polydisperse polymer solutions are desirable for electrospinning , 2014 .

[24]  H. Brittain Polymorphism and solvatomorphism 2010. , 2012, Journal of pharmaceutical sciences.

[25]  A. Hawe,et al.  Physico-chemical lyophilization behavior of mannitol, human serum albumin formulations. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[26]  Timo Laaksonen,et al.  Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. , 2011, International journal of pharmaceutics.

[27]  Lei Wang,et al.  Preparation and electrochemical properties of LiFePO4/C nanoparticles using different organic carbon sources , 2013, Journal of Nanoparticle Research.

[28]  A. T. Sobczyk,et al.  Electrospraying route to nanotechnology: An overview , 2008 .

[29]  R. Hüttenrauch,et al.  Mechanical Activation of Pharmaceutical Systems , 1985, Pharmaceutical Research.

[30]  G. Van den Mooter,et al.  Solution calorimetry as an alternative approach for dissolution testing of nanosuspensions. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[31]  A. Saleki-Gerhardt,et al.  Assessment of disorder in crystalline solids , 1994 .

[32]  V. Jannin,et al.  Approaches for the development of solid and semi-solid lipid-based formulations. , 2008, Advanced drug delivery reviews.

[33]  N. Trasi,et al.  Thermodynamics of Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs-Impact of a Second Drug on the Solution Phase Behavior and Implications for Combination Products. , 2015, Journal of pharmaceutical sciences.

[34]  The fate of ritonavir in the presence of darunavir. , 2014, International journal of pharmaceutics.

[35]  Christian Clasen,et al.  Determination of viscoelastic and rheo-optical material functions of water-soluble cellulose derivatives , 2001 .

[36]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[37]  Tim R. Dargaville,et al.  Electrospraying of polymers with therapeutic molecules: State of the art , 2012 .

[38]  G. Van den Mooter,et al.  One‐step production of darunavir solid dispersion nanoparticles coated with enteric polymers using electrospraying , 2016, The Journal of pharmacy and pharmacology.

[39]  V. Caron,et al.  Transformation of pharmaceutical compounds upon milling and comilling: the role of T(g). , 2007, Journal of pharmaceutical sciences.